Bariatric surgery has been found to reduce opioid use as well as facilitate weight loss among people with moderate knee osteoarthritis (OA) and a body mass index (BMI) of ≥40 kg/m2. A study in attempted to establish the long-term value of the two most common bariatric surgery techniques: the Roux-en-Y gastric bypass (RYGB) and laparoscopic sleeve gastrectomy (LSG).
Inside Harvard's Cautious Reopening Approach in the Year of Covid | News thecrimson.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thecrimson.com Daily Mail and Mail on Sunday newspapers.
A recent study published in Arthritis Care & Research estimates that 858,000 Americans use opioids such as tramadol and oxycodone for their knee pain, equating to $14 billion in lifetime opioid-related societal costs, or nearly $0.5 billion annually.
E-Mail
Although guidelines do not recommend use of opioids to manage pain for individuals with knee osteoarthritis, a recent study published early online in
Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Professionals, estimates that 858,000 Americans use opioids such as tramadol and oxycodone for their knee pain, equating to $14 billion in lifetime opioid-related societal costs, or nearly $0.5 billion annually.
A team led by Elena Losina, PhD, Robert W. Lovett Professor of Orthopedic Surgery, of Brigham and Women s Hospital, used a computer simulation to estimate the annual and lifetime contribution of opioids to knee osteoarthritis-related costs. The researchers show the direct medical cost of knee osteoarthritis treatment including opioids totals $7.45 billion or 53 percent of the total lifetime costs. The remaining 47 percent of lifetime costs to society is used to pay for lost productivity at wor
Date Time
Share
Study Shows Opioid Use among U.S. Patients with Knee Osteoarthritis Costs 14 Billion Dollars in Societal Costs
Although guidelines do not recommend use of opioids to manage pain for individuals with knee osteoarthritis, a recent study published early online in Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Professionals, estimates that 858,000 Americans use opioids such as tramadol and oxycodone for their knee pain, equating to $14 billion in lifetime opioid-related societal costs, or nearly $0.5 billion annually.
A team led by Elena Losina, PhD, Robert W. Lovett Professor of Orthopedic Surgery, of Brigham and Women’s Hospital, used a computer simulation to estimate the annual and lifetime contribution of opioids to knee osteoarthritis-related costs. The researchers show the direct medical cost of knee osteoarthritis treatment including opioids totals $7.45 billion or 53 percent of the